Literature DB >> 24033817

Analysis of factors affecting the life quality of the patients with late stomach cancer.

Yan-Mei Ma1, Cai-Feng Ba, Yu-Bin Wang.   

Abstract

AIMS AND
OBJECTIVES: To provide a theoretical basis for the clinical care of patients with late stomach cancer, we investigated the life quality and analysed its related factor in the patients with late stomach cancer.
BACKGROUND: Due to the lack of effective screening methods, stomach cancer usually has been in the advanced stage when patients are diagnosed. However, the treatment for late stomach cancer is a tough problem in today's medicine. Chemotherapy or radiotherapy brings patients physiological and psychological distress and heavy financial burden, affecting patients' therapeutic effects, prognosis and life quality.
DESIGN: The patients with late stomach cancer were included, and then, questionnaires about the life quality were completed.
METHODS: Questionnaires including European Organisation for Research on Treatment of Cancer Quality of Life Questionnaire-Core 30, Social Support Rating Scale, Medical Coping Modes Questionnaire and Self-rating Anxiety Scale were completed by 173 patients with late stomach cancer who received treatment in our hospital between May 2010 and May 2011. Correlation analyses were performed.
RESULTS: The overall score of the life quality of the patients with late stomach cancer was only 29·54 ± 12·21. The social support, medical coping modes, anxiety and patients' clinical data (except radiotherapy) markedly affected the overall life quality of the patients with late stomach cancer (p < 0·05).
CONCLUSION: The life quality of the patients with late stomach cancer is poor and is associated with many factors. RELEVANCE TO CLINICAL PRACTICE: This study provides a theoretical basis for better nursing the patients with late stomach cancer and improving their life quality.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  late stomach cancer; life quality; life quality-related factors

Mesh:

Year:  2013        PMID: 24033817     DOI: 10.1111/jocn.12311

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  6 in total

Review 1.  Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences.

Authors:  Alison Rowsell; Samantha C Sodergren; Vassilios Vassiliou; Anne-Sophie Darlington; Marianne G Guren; Bilal Alkhaffaf; Chantelle Moorbey; Kristopher Dennis; Mitsumi Terada
Journal:  Gastric Cancer       Date:  2022-06-11       Impact factor: 7.701

2.  Quality of Life and Its Determinants in Adult Cancer Patients Undergoing Chemotherapy Treatment in Pakistan.

Authors:  Parveen Chagani; Yasmin Parpio; Raisa Gul; Adnan A Jabbar
Journal:  Asia Pac J Oncol Nurs       Date:  2017 Apr-Jun

3.  Coping, mood and health-related quality of life: a cross-sectional study in Chinese patients with advanced lung cancer.

Authors:  Yaping He; Hong Jian; Meiqiong Yan; Jingfen Zhu; Guohong Li; Vivian W Q Lou; Jieling Chen
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

4.  Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets.

Authors:  Dan Li; Shixin Xiang; Jing Shen; Mingtao Xiao; Yueshui Zhao; Xu Wu; Fukuan Du; Huijiao Ji; Mingxing Li; Qijie Zhao; Parham Jabbarzadeh Kaboli; Xiao Yang; Zhangang Xiao; Bo Qin; Qinglian Wen
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

5.  'FLARE' of tumor marker in advanced gastric cancer treated with first-line systemic therapy.

Authors:  Fangyuan Zhang; Menglan Zhai; Jinru Yang; Lei Zhao; Zhenyu Lin; Jing Wang; Tao Zhang; Dandan Yu
Journal:  Therap Adv Gastroenterol       Date:  2022-09-28       Impact factor: 4.802

6.  Psychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-131.

Authors:  Hong-Xia Wu; Hua Zhong; Yue-Dong Xu; Cui-Ping Xu; Ying Zhang; Wei Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-02       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.